Optimal Long-Acting Injectable Antipsychotic Management During COVID-19

MacLaurin, Sarah A.Mulligan, CaitlinVan Alphen, Manjola UjkajFreudenreich, Oliver2023-08-142021-01-12MacLaurin, Sarah A., Caitlin Mulligan, Manjola Ujkaj Van Alphen, Oliver Freudenreich. "Optimal Long-Acting Injectable Antipsychotic Management During COVID-19." J. Clin. Psychiatry 82, no. 1 (2021). DOI: 10.4088/jcp.20l137301555-2101https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37376775Letter describes our clinics experience with provision of long-acting injectable antipsychotics during the COVID-19 pandemic.N/A (letter)en-USPsychiatry and Mental healthOptimal Long-Acting Injectable Antipsychotic Management During COVID-19Journal Article2023-08-1410.4088/jcp.20l13730